Jeffrey Alan Tornheim, M.D., M.P.H.

Headshot of Jeffrey Alan Tornheim
  • Assistant Professor of Medicine

Languages: English, Spanish


Jeff Tornheim, M.D., MPH, is a member of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, and is a term member of the Council on Foreign Relations.

Dr. Tornheim graduated with a B.A. in International Development and Economics from Brandeis University, received his medical and public health degree from the Mount Sinai School of Medicine, completed a combined residency in Internal Medicine and Pediatrics at Yale University School of Medicine and a clinical fellowship in Infectious Diseases at Johns Hopkins University School of Medicine. 

Prior to completing his medical education, he worked on strengthening health systems for returning refugees to South Sudan, studied the epidemiology of pneumonia and diarrhea in Kenya with the Centers for Disease Control and Prevention (CDC) International Emerging Infections Program, studied adherence to latent tuberculosis treatment at the New York City Department of Health and Mental Hygiene in the Bureau of TB Control, and volunteered in an East Harlem free clinic.  During his public health degree, he evaluated the impact of water policy on rates of pediatric diarrhea as well as Chagas Disease epidemiology and treatment in Bolivia through the Fogarty International Clinical Scholars Program.  His interest in clinical outcomes for underserved populations has led to research, teaching, and clinical practice in Bolivia, India, Kenya, Peru, Rwanda, South Africa, South Sudan, Uganda, and the United States.

His current NIH-supported research explores the application of whole genome sequencing, drug level testing, transcriptional and metabolomic profiling, and biomarker assessments to improved health outcomes in the treatment of adults and children with drug resistant tuberculosis in India. more


  • Assistant Professor of Medicine
  • Assistant Professor of Pediatrics

Departments / Divisions

Centers & Institutes



  • MD; Mount Sinai School of Medicine (2010)


  • Internal Medicine/Pediatrics; Yale-New Haven Hospital (2014)


  • Infectious Diseases; Johns Hopkins University School of Medicine (2017)

Board Certifications

  • American Board of Internal Medicine (Infectious Disease) (2016)
  • American Board of Internal Medicine (Internal Medicine) (2014)
  • American Board of Pediatrics (Pediatrics) (2014)

Research & Publications

Research Summary

Dr. Tornheim's research explores whether a combination of MDR-TB drug susceptibility tests using whole genome sequencing and minimum inhibitory concentrations can yield personalized treatment options for improved MDR-TB treatment outcomes.

Selected Publications

Ajbani K, Kazi M, Tornheim J, Naik S, Soman R, Shetty A, Rodrigues C. “Pyrosequencing to resolve discrepant Xpert MTB/RIF and Mycobacterial Growth Indicator Tube 960.” Lung India. 2018 Mar-Apr;35(2):168-170. doi: 10.4103/lungindia.lungindia_71_17.

Tornheim JA, Dooley KE. “Tuberculosis associated with HIV infection.” Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0028-2016. Review.

Activities & Honors


  • W. Leigh Thompson Excellence in Research: Clinical Research Faculty Award, Johns Hopkins Department of Medicine, 2018
  • Fogarty International Clinical Scholar, National Institutes of Health, 2016 - 2017
  • Fellow Teaching Award, Hopkins Bayview Medical Housestaff Training Program
  • Clinician Scientist Career Development Award, Johns Hopkins University School of Medicine

Videos & Media

Lectures and Presentations

  • Linezolid Experience Among MDR-TB Patients in Mumbai
    Presentation, 2018 Research Retreat, Baltimore, MD (03/16/2018)
    Johns Hopkins Department of Medicine
  • Linezolid Experience Among MDR-TB Patients in Mumbai
    Presentation, RePORT India Annual Meeting, New Delhi, India (02/15/2018)
  • Drug Susceptibility of Rifampin-resistant Tuberculosis using Whole Genome Sequencing to Identify Genes of Interest in Pune, India
    Presentation, RePORT India Annual Meeting, New Delhi, India (02/15/2018)
  • Drug Susceptibility of Rifampin-resistant Tuberculosis using Whole Genome Sequencing to Identify Genes of Interest in Pune, India
    Presentation, 48th Annual Union World Conference of Lung Health, Guadalajara, Mexico (10/12/2017)
  • Linezolid Experience among MDRTB Patients in Mumbai, ERS International Congress.
    Presentation, European Respiratory Society,, Milan, Italy (09/13/2017)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button